Elicio Therapeutics (ELTX) Debt Ratio (2020 - 2026)

Elicio Therapeutics (ELTX) has reported Debt Ratio for 5 consecutive years, with 0.3 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Debt Ratio fell 3.75% year-over-year to 0.3; the trailing twelve-month figure through Jun 2026 stood at 0.3 (down 3.75% YoY), and the FY2025 full-year result was 0.36, down 48.84% from the prior year.
• Debt Ratio slipped to 0.3 in Q2 2026 per ELTX's latest filing, from 0.42 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.71 in Q4 2024 and bottomed at 0.3 in Q2 2026.
• Historically, Debt Ratio has averaged 0.41 across 3 years, with a median of 0.35 in 2025.
• The sharpest annual moves came in 2025 and 2026: Debt Ratio tumbled 48.84% in 2025, then decreased 3.75% in 2026.
• Over 3 years, Debt Ratio stood at 0.71 in 2024, then tumbled by 48.84% to 0.36 in 2025, then declined by 16.33% to 0.3 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.3, 0.42, and 0.36 for Q2 2026, Q1 2026, and Q4 2025 respectively.